Product Name | MF | CAS | Details |
---|
Efluconazole impurity 40 | C12H21NO4 | 135206-86-9 | Details |
Efluconazole impurity 39 | C7H13NO3 | 146432-17-9 | Details |
Efluconazole impurity 36 | C15H18F2O3 | 135267-12-8 | Details |
Efluconazole Impurity 37 | C17H21F2N3O3 | 135133-23-2 | Details |
Ritonavir impurity 29 | C11H8N2O5S | 144163-97-3 | Details |
Efluconazole impurity 31 | C13H15F2N3O4S | 161287-08-7 | Details |
Etibant | C59H89N19O13S | 130308-48-4 | Details |
Efluconazole Impurity 33 | C7H13NO3 | 135206-87-0 | Details |
Diphenylphosphine oxide | C12H11OP | 4559-70-0 | Details |
Atebant impurity 7 | C15H27N5O3 | 259882-53-6 | Details |
Efluconazole impurity 30 | C14H17F2N3O6S2 | 153522-54-4 | Details |
Ritonavir impurity 30 | C4H5NOS | 38585-74-9 | Details |
Efluconazole impurity 24 | C13H15NO | 188904-84-9 | Details |
Efluconazole impurity 34 | C12H21NO4 | 135270-08-5 | Details |
Ritonavir Impurity 33 | C32H36N2O | 156732-15-9 | Details |
Pentoxifylline EP Impurity I | C14H14N4O2 | 55247-90-0 | Details |
Efluconazole impurity 28 | C18H22F2N4O | 2252350-11-9 | Details |
Emtricitabine Impurity 7 | C8H8FN3O4S | 1238210-10-0 | Details |
Efluconazole impurity 23 | C13H17NO2 | 19980-00-8 | Details |
Efluconazole Impurity 25 | C6H11N | 148133-82-8 | Details |
Geritinib | C29H44N8O3 | 1254053-43-4 | Details |
Haloperidol EP Impurity L | C8H7FO | 403-42-9 | Details |
Cloverdipine butyrate impurity 16 | C22H25Cl2NO6 | 1898262-47-9 | Details |
Atebant Impurity 4 | C10H11NO2 | 103733-65-9 | Details |
Piropilone impurity 14 | C15H20BrN3S | 87691-94-9 | Details |
Venlafaxine hydrochloride EP Impurity F | C17H26ClNO | 93413-79-7 | Details |
Ritonavir impurity 32 | C23H32N2O3 | 144163-85-9 | Details |
Ritonavir impurity 31 | C23H27N3O3S | 144164-11-4 | Details |
Dachronine impurity 7 | C12H16O2 | 50743-14-1 | Details |
Antiuric acid 4 | C26H24Cl4O8 | 25355-92-4 | Details |
Bedaquinoline impurity 10 | C32H29BrN2O | 1032468-56-6 | Details |
Imiquimod USP related Substance A | C14H15N3 | 99010-24-9 | Details |
Glycine impurity 13 | C9H9Cl2NO2 | 1008008-56-7 | Details |
Imbandronate sodium impurity 22 | C5H11NO2 | 24549-12-0 | Details |
Dobutamine 9 | C11H16O2 | 67952-38-9 | Details |
Carpotriol beta isomer | C27H40O3 | 934338-44-0 | Details |
Imiquimod USP related Substance C | C14H14ClN3 | 99010-64-7 | Details |
Lufeamide impurity 11 | C12H10ClO3P | 2524-64-3 | Details |
3-(bromomethyl) -5-fluorobenzonitrile | C8H5BrFN | 853368-35-1 | Details |
Repaglinide EP Impurity D | C29H40N2O4 | 147770-06-7 | Details |
Phenylethylamine | C10H17NO5S | 2624-44-4 | Details |
Antiuric acid 3 | C13H13Cl3O4 | 27929-18-6 | Details |
Oseltamivir Impurity 122 | C14H22O5 | 943515-58-0 | Details |
Isopropyl d-camphor sulfonate | C13H22O4S | 247078-58-6 | Details |
Imiquimod USP related Substance E | C13H17N3 | 99010-09-0 | Details |
Imiquimod impurity 14 | C9H7NO | 611-36-9 | Details |
Imiquimod | C14H16N4 | 99011-02-6 | Details |
Imiquimod impurity 16 | C13H15N3O2 | 99009-85-5 | Details |
Lamotrigine | C9H7Cl2N5 | 84057-84-1 | Details |
Lufeamide impurity 13 | C7H5F2N3 | 106308-60-5 | Details |
Imiquimod impurity 11 | C13H14N4 | 853792-81-1 | Details |
Dacronine impurity 6 (hydrochloride) | C9H20ClN | 80840-88-6 | Details |
USP related Substance A | C12H12Cl2O4 | 1217-67-0 | Details |
Glycine impurity 12 | C9H9Cl2NO2 | 1217999-35-3 | Details |
Imiquimod impurity 10 | C14H15N3O | 99010-99-8 | Details |
Lufeamide impurity 12 | C10H9F2N3O | 1364193-40-7 | Details |
Lufeamide Impurity 9 | C7H6F2O | 19064-18-7 | Details |
Imiquimod USP related Substance B | C14H15N3O | 99010-63-6 | Details |
Azisartan Impurity 106 | C4H10N2O | 30533-08-5 | Details |
Efluconazole Impurity 10(mesylate) | C13H15F2N3O4S | 1175536-50-1 | Details |
Englil Net Impurity 119 | C17H16BrClO2 | 2744280-73-5 | Details |
Emtricitabine 8 | C8H10FN3O4S | 152128-77-3 | Details |
Ibandronate sodium impurity 23 | C13H25NO4 | 1226358-39-9 | Details |
Lispran | C22H23N7O | 1825352-65-5 | Details |
Piropilone impurity 10 | C20H46BrN2+ | 1621467-18-2 | Details |
Dimethyl fumarate | C6H8O4 | 624-49-7 | Details |
Piropilone (hydrochloride) | C23H31ClN4O2S | 129273-38-7 | Details |
Irbesartan impurity 22 | C14H10BrN | 135689-88-2 | Details |
Piropilone Impurity 13 | C12H26N2O2 | 92036-96-9 | Details |
Rispran impurity 1 | C22H23N7O2 | 2250441-24-6 | Details |
Metoprolol 24 | C15H24N2O4 | 138768-62-4 | Details |
Phenolsulfoethylamine impurity 1 | C7H8O5S | 2429952-18-9 | Details |
Niticinone | C14H10F3NO5 | 104206-65-7 | Details |
Sodium citrate | C6H9NaO7 | 68-04-2 | Details |
Aminohexenoic acid EP Impurity E | C7H11NO4 | 1378466-25-1 | Details |
Bedaquinoline impurity 11 | C32H29BrN2O | 1032468-55-5 | Details |
Aminohexenoic acid (hydrochloride) | C6H12ClNO2 | 1391054-02-6 | Details |
Mixture of diastereoisomers of aminohexenoic acid EP impurity C | C7H10N2O2 | 71107-19-2 | Details |
Lufeamide Impurity 8 | C4H4O2 | 922-67-8 | Details |
Good for uric acid | C13H12Cl2O4 | 58-54-8 | Details |
2,4, 6-trihydroxybenzoic acid hydrate | C7H8O6 | 71989-93-0 | Details |
Imiquimod impurity 6 | C14H16N4O | 1807606-78-5 | Details |
Lamotrigine EP Impurity E | C7H4Cl2O2 | 50-45-3 | Details |
2,4, 6-trihydroxybenzoic acid | C7H6O5 | 83-30-7 | Details |
Imiquimod Impurity 5 | C14H16N4O | 112668-45-8 | Details |
Carpotriol EP Impurity A | C27H38O3 | 126860-83-1 | Details |
Dacronine | C18H27NO2 | 586-60-7 | Details |
Bedaquinoline impurity 9 | C30H27BrN2O2 | 955404-04-3 | Details |
Imiquimod impurity 15 | C9H6N2O3 | 50332-66-6 | Details |
Imiquimod impurity 12 | C21H22N4 | 415726-68-0 | Details |
Dacronine impurity 8 | C12H16O2 | 61405-66-1 | Details |
Imiquimod impurity 9 | C15H18N4 | 853793-02-9 | Details |
Lufeamide Impurity 5 | C10H10N4O | 80819-65-4 | Details |
Lufeamide Impurity 4 | C12H11F2N3O2 | 869501-51-9 | Details |
Lufeamide Impurity 2 | C10H7F2N3O2 | 166196-11-8 | Details |
Lufeamide | C10H8F2N4O | 106308-44-5 | Details |
Lufeamide impurity 1 | C11H9F2N3O2 | 217448-86-7 | Details |
Acetazolamide impurity 12 | C12H13N3OS2 | 95046-30-3 | Details |
Rabeprazole impurity 25 | C10H13Cl2NO | 209914-31-8 | Details |
Ezetimibe Impurities 63 | C33H30F2N2O5 | 1185883-40-2 | Details |
Product Total: Product Page: | ||||
164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 |